Skip to content

US · THQ · ASSET MANAGEMENT

Abrdn Healthcare Opportunities Fund (THQ) intrinsic value and stock valuation

$17.12as of 2026-11-21 · Mkt cap 796.43M

Data updated · price as of 2026-11-21

Fairly valuedIC value is within 20% of the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Abrdn Healthcare Opportunities Fund DCF and intrinsic value

InvestorsCraft values THQ with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from THQ’s statements →

Abrdn Healthcare Opportunities Fund Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Financial Services · Asset Management Philadelphia, PA 19103 teklacap.com

How the business is doing

Fiscal 2014–2025, USD

Revenue
-$-100.83M
20142025
Net income
-$-114.84M
20142025
Free cash flow
$350K-64.7% 5y CAGRd
20152025
Total equity
$740.7M-2.4% 5y CAGRd
20142025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2014–2025, USD
20252024202320222021
Revenue-$-100.83M$191.1M$80.5M$69.6M$196.5M
Operating income-$-114.84M$204.5M$13.5M-$-82.43M$194.7M
Net income-$-114.84M$189.6M$52.8M-$-86.25M$194.7M
EPSd-$-2.78M$4.58M$1.28M-$-2.09M$4.71M
Operating cash flow$350K$78.3M$55.8M$55.6M$33.1M
Capital expenditure$0.00$0.00$0.00$0.00$0.00
Free cash flow$350K$78.3M$55.8M$55.6M$33.1M
Total assets$970.2M$1.17B$1.06B$1.07B$1.24B
Total debt$225M$225M$225M$225M$225M
Net debt$225M$225M$225M$207.6M$225M
Total equity$740.7M$943.9M$832.5M$835.6M$977.4M
Cash and short-term investments$5.49M$61.4M$40.2M$17.4M$0.00
Income statement
20252024202320222021
Revenue-$-100.83M$191.1M$80.5M$69.6M$196.5M
Cost of revenue$12.9M$15M$12.3M$13.2M$2.13M
Gross profit-$-113.75M$191.1M$68.2M$56.4M$196.5M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$1.08M$1.5M$1.31M$1.48M$1.28M
Other expenses$10K$40K$590K$620K$610K
Operating expenses$1.1M$1.54M$1.9M$2.1M$1.89M
Cost and expenses$14M$1.54M$14.6M$152M$1.89M
Interest income$7.19M$9.24M$7.13M$4.9M$4.56M
Interest expense$12.9M$15M$13.1M$3.83M$2.13M
Depreciation and amortization$0.00$0.00$52.4M$230K$240K
Ebitda-$-114.84M$204.5M$65.9M-$-82.2M$194.9M
Operating income-$-114.84M$204.5M$13.5M-$-82.43M$194.7M
Total other income/expenses, net-$-12.92M-$-14.97M$39.3M-$-3.83M$0.00
Income before tax-$-114.84M$189.6M$52.8M-$-86.25M$194.7M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income-$-114.84M$189.6M$52.8M-$-86.25M$194.7M
Weighted average shares outstanding$41.4M$41.4M$41.2M$41.4M$41.3M
Weighted average diluted shares outstanding$41.4M$41.4M$41.2M$41.4M$41.3M
Balance sheet
20252024202320222021
Cash and short-term investments$5.49M$61.4M$40.2M$17.4M$0.00
Net receivables$4.32M$2.27M$2.16M$3.27M$2.32M
Inventory$0.00$0.00$42.3M$0.00$0.00
Total current assets$4.53M$61.4M$2.16M$3.27M$2.32M
Property, plant and equipment, net$0.00$0.00$0.00$0.00$0.00
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$960.2M$1.17B$1.06B$1.06B$1.24B
Total non-current assets$965.7M$1.17B$1.06B$1.06B$1.24B
Total assets$970.2M$1.17B$1.06B$1.07B$1.24B
Accounts payable$660K$0.00$2.81M$1.5M$35.4M
Short-term debt$225M$225M$225M$225M$0.00
Deferred revenue$0.00$0.00$0.00-$-223.5M$0.00
Total current liabilities$660K$3.78M$2.81M$1.5M$35.4M
Long-term debt$225M$225M$225M$225M$225M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$228.9M$229.2M$225M$225M$225M
Capital lease obligations$0.00$0.00$0.00$0.00$0.00
Total liabilities$229.5M$229.2M$229.5M$230.5M$263.1M
Common stock$410K$410K$410K$410K$410K
Retained earnings$65.8M$184.5M$40.2M$43.2M$185.3M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$740.7M$943.9M$832.5M$835.6M$977.4M
Total investments$960.2M$1.23B$1.1B$1.06B$1.24B
Total debt$225M$225M$225M$225M$225M
Net debt$225M$225M$225M$207.6M$225M
Cash flow statement
20252024202320222021
Net income-$-114.84M$189.6M$52.8M-$-86.25M$194.7M
Depreciation and amortization$0.00$0.00$0.00$0.00$0.00
Stock-based compensation$0.00$0.00$0.00$0.00$0.00
Change in working capital-$-560K-$-170K$1.11M$1.08M$340K
Accounts receivable$30K-$-120K-$-70K-$-50K$150K
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$0.00$40K$0.00$0.00$0.00
Net cash provided by operating activities$350K$78.3M$55.8M$55.6M$33.1M
Investments in property, plant and equipment$0.00$0.00$0.00$0.00$0.00
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities$32.1M$95.6M$74M$10.8M$0.00
Common stock issued$0.00$0.00$0.00$0.00$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid-$-88.38M-$-78.26M-$-55.81M-$-55.56M-$-55.72M
Net cash used for financing activities-$-88.38M-$-78.26M-$-55.81M-$-55.56M-$-55.72M
Net change in cash$5.49M-$0.00-$0.00-$0.00-$-22.65M
Cash at end of period$5.49M$0.00$0.00$0.00$0.00
Operating cash flow$350K$78.3M$55.8M$55.6M$33.1M
Capital expenditure$0.00$0.00$0.00$0.00$0.00
Free cash flow$350K$78.3M$55.8M$55.6M$33.1M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Abrdn Healthcare Opportunities Fund

        Managed by Tekla Capital Management LLC, the Tekla Healthcare Opportunities Fund operates as a closed-end, balanced mutual fund. This fund strategically allocates capital across global public equity and debt markets, with a core investment objective of acquiring securities from companies within the healthcare sector. It also invests in various pooled investment vehicles. For its fixed income component, the fund holds corporate debt securities across the full spectrum of credit ratings. Established on April 2, 2014, and domiciled in the United States, its portfolio performance is measured against both the S&P 1500 Healthcare Index and the S&P 500 Index.

        CEO
        Daniel R. Omstead
        Employees
        0
        Beta
        0.89

        Explore

        Frequently asked questions

        What is the intrinsic value of Abrdn Healthcare Opportunities Fund (THQ)?

        Abrdn Healthcare Opportunities Fund (THQ) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is THQ undervalued?

        THQ trades at a price of $17.12 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.